Simone N. Koole

Gynecologic Oncology Group — United States

Medicine · Health Sciences

13h-index2.1kcitations37works4.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Ovarian cancer diagnosis and treatment(22), Intraperitoneal and Appendiceal Malignancies(20), Economic and Financial Impacts of Cancer(6), Health Systems, Economic Evaluations, Quality of Life(4), Cancer Immunotherapy and Biomarkers(3)

Publications37 total

Budget Impact Analysis of Hyperthermic Intraperitoneal Chemotherapy With Interval Cytoreductive Surgery in Ovarian Cancer
JCO Oncology Practice·2025
Neo-adjuvant pembrolizumab in stage IV high-grade serous ovarian cancer: the phase II Neo-Pembro trial
Nature Communications·2025· 3 citedOpen Access
EV321/#1109  A budget impact analysis of the addition of hyperthermic intraperitoneal chemotherapy to interval cytoreductive surgery in ovarian cancer
2024
770P Neoadjuvant pembrolizumab in stage IV ovarian cancer: The phase II Neo-Pembro trial
Annals of Oncology·2024Open Access
1535O Cost and value of EMA-registered checkpoint inhibitors for solid tumours in the Netherlands
Annals of Oncology·2024Open Access
Tumour microenvironment characterisation to stratify patients for hyperthermic intraperitoneal chemotherapy in high-grade serous ovarian cancer (OVHIPEC-1)
British Journal of Cancer·2024· 4 citedOpen Access
Testing dilemmas in the clinic: Lessons learned from biomarker-based drug development
Cancer Cell·2024· 2 cited
Lessons learned from postmarketing withdrawals of expedited approvals for oncology drug indications
The Lancet Oncology·2024· 28 cited
Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy in Patients With Advanced Ovarian Cancer (OVHIPEC-1): Final Survival Analysis of a Randomised, Controlled, Phase 3 Trial
Obstetrical & Gynecological Survey·2024Open Access
Differences in time to patient access to innovative cancer medicines in six European countries
International Journal of Cancer·2023· 14 citedOpen Access
1723P Improving access to molecular tumour boards for complex genomic profiles: A healthcare policy from the Netherlands
Annals of Oncology·2023Open Access
Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy in patients with advanced ovarian cancer (OVHIPEC-1): final survival analysis of a randomised, controlled, phase 3 trial
The Lancet Oncology·2023· 102 citedOpen Access
Adjuvant immune checkpoint blockade revisited
The Lancet Oncology·2023· 7 cited
Final survival analysis of the phase III OVHIPEC-1 trial of hyperthermic intraperitoneal chemotherapy in ovarian cancer after ten year follow-up.
Journal of Clinical Oncology·2023· 1 cited
Targeted combination therapies in oncology: Challenging regulatory frameworks designed for monotherapies in Europe
Drug Discovery Today·2023· 5 citedOpen Access
Reply to: Comments on “Effect of <scp>HIPEC</scp> according to <scp>HRD</scp>/<i>BRCA</i><scp>wt</scp> genomic profile in stage <scp>III</scp> ovarian cancer: Results from the phase <scp>III OVHIPEC</scp> trial”
International Journal of Cancer·2022· 1 cited
Effect of <scp>HIPEC</scp> according to <scp>HRD</scp>/<scp><i>BRCA</i>wt</scp> genomic profile in stage <scp>III</scp> ovarian cancer: Results from the phase <scp>III OVHIPEC</scp> trial
International Journal of Cancer·2022· 40 citedOpen Access
Cell-Free DNA at Diagnosis for Stage IV Non-Small Cell Lung Cancer: Costs, Time to Diagnosis and Clinical Relevance
Cancers·2022· 5 citedOpen Access
Effects of and Lessons Learned from an Internet-Based Physical Activity Support Program (with and without Physiotherapist Telephone Counselling) on Physical Activity Levels of Breast and Prostate Cancer Survivors: The PABLO Randomized Controlled Trial
Cancers·2021· 21 citedOpen Access
Costs, throughput time, and proportion of valid test results, a model-based analysis of liquid biopsies for stage IV non-small cell lung cancer.
Journal of Clinical Oncology·2021
page 1 of 2Next →

Frequent Co-authors

Willemien J. van Driel(27), Gabe S. Sonke(25), Henriëtte J.G. Arts(15), Ralph H.M. Hermans(14), Henk W.R. Schreuder(13), Ignace H. J. T. de Hingh(13), Karolina Sikorska(12), Jules H. Schagen van Leeuwen(12), Koen Van de Vijver(11), Valesca P. Retèl(11), Jacobus van der Velden(10), Arend G. J. Aalbers(10), Victor J. Verwaal(10), Neil K. Aaronson(10), Jacobien M. Kieffer(7), Peter A. van Dam(7), Peter Vuylsteke(7), Marta López‐Yurda(6), Wim H. van Harten(6), Leon F.A.G. Massuger(5)